EpicDefense
EpicDefense is a science-backed, next-generation immunobiotic formula that supports year-round immune defense, providing daily and seasonal wellness. It regulates immunity, optimizes mucosal immune function, boosts immune signaling molecules, and supports respiratory and nasal comfort.**
How to buy?
A valid Practitioner account is required for direct purchases from our website. Let’s get you registered!
EpicDefense Benefits
- Fortifies immune function with consistent daily support**
- Delivers year-round, gut-powered immunity**
- Regulates healthy immune balance**
- Supports respiratory wellness & comfort**
- Optimizes mucosal immune function**
- Promotes healthy nasal airflow & comfort**
- Provides immune support for seasonal challenges**
- Boosts key immune-signaling molecules**
- Promotes balanced inflammatory responses**
What are Immunobiotics?
Probiotics are great for your gut, helping digestion and keeping your body balanced. Now discover the next evolution in human microbiome science—immunobiotics— the new standard in immune wellness.
Immunobiotics are defined as “microbes that promote immune health by activating gut microbiome-induced immunity.” These powerful probiotics and postbiotics supercharge your immune system, working through your gut microbiome to fortify your body’s natural defenses—creating the ripple effect of whole-body health.
EpicDefense brings you potent, clinically studied next-generation immunobiotics—LGG®, BB-12®, and EpiCor®—backed by science to ease seasonal challenges, promote nasal and respiratory comfort, and support daily, year-round immunity. Our formula also includes Albion® Minerals’ immune-promoting zinc bisglycinate, chelated for ultra absorption and bioavailability.
Embrace a stronger, healthier you with EpicDefense—the new era of immunobiotic-powered immune wellness!
EpicDefense Studies
|
Form/Duration |
Study Details and Results |
Reference |
|---|---|---|
|
Lactobacillus LGG® + Bifidobacterium BB-12® |
Randomized, double-blind, placebo-controlled trial 12 weeks | 198 human subjects ↓ Respiratory discomfort duration & severity ↑ Health-related quality of life (HRQL) |
DOI: 10.1017/S0007114512004138 |
|
Lactobacillus LGG® + Bifidobacterium BB-12® |
In vivo studies ↑ Gut microflora balance ↑ Beneficial bacteria growth ↑ Microbiome health |
DOI: 10.1080/23311932.2018.1452839 |
|
Lactobacillus LGG® |
Randomized, double-blind, placebo-controlled trial 3 months | 281 children ↑ Respiratory health ↓ Respiratory instances lasting more than three days ↓ Days with respiratory discomfort |
DOI: 10.1016/j.clnu.2009.09.008 |
(continued):
|
Form/Duration |
Study Details and Results |
Reference |
|---|
|
Bifidobacterium BB-12® |
Randomized, double-blind, placebo-controlled trial 6 weeks | 211 human subjects ↑ IgG ↑IgA levels ↑ Total antibody concentration |
DOI: 10.1017/S000711451100420X |
|
EpiCor® |
Randomized, double-blind, placebo-controlled trial 12 weeks | 96 human subjects ↑ Nasal & airflow comfort ↓ Nasal discharge ↓ Nasal concerns severity & duration |
DOI: 10.1007/s12325-009-0057-y |
|
Zinc |
Investigative study 14 days 54 human subjects ↑ Natural Killer cell functionality ↓ Circulating innate lymphoid cell counts & frequencies |
DOI: 10.1186/s12967-025-06259-y |